Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Reexamination Certificate
2007-04-17
2007-04-17
Minnifield, Nito (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
C424S184100, C424S234100, C424S236100, C424S237100, C424S093100, C424S093400, C424S093440, C514S002600
Reexamination Certificate
active
10807575
ABSTRACT:
A composition prepared from intact killed cells of isolated β-hemolyticStreptococcus agalactiaeand a concentrated extract of a culture of β-hemolyticStreptococcus agalactiae, is effective for the protection of fish against infection by the same and other virulent strainsStreptococcus agalactiae.
REFERENCES:
patent: 4425330 (1984-01-01), Norcross et al.
patent: 6379677 (2002-04-01), Klesius et al.
patent: WO 2005/089447 (2005-09-01), None
Evans et al, Vaccine, 2004, 22:3769-3773.
Dal et al, FEMS Microbiology Letters, 1983, 16:89-94.
Chun-Yao, Dai-B, Jun. 2003, 63/12:5709 dissertation abstract only.
de la Rosa et al, J. Clinical Microbiology, 1992, 30/4:1019-1021.
Neely et al, Infection and Immunity, 2002, 70/7:3904-3914.
Kawamura et al, Int. J. Sys. Evol. Microbiol., 2005, 55:961-965.
Hagaki et al, Int. J. Tissue React., 2003, XXV/2:47-50.
Miller et al, Acta Tropica, 2004, 91:53-68.
Berridge et al, Vet. Microbiol., 2001, 78:165-173.
Zlotkin et al, Applied and Environ. Microbiology, 1998, 64/10:4065-4067.
Ezaki et al, Int. J. Sys. Bacteriol., 1986, 36/2:345-347.
Berridge, Dai-B, Feb. 1999, 59/08:3789 dissertation abstract only.
Nakanishi et al, Vaccine, 2002, 20:3764-3769.
Pasnik et al, J. Fish Diseases, Apr. 2005, 28/4:205 abstract only.
Evans et al, Aquaculture, 2004, 233(1-4):15-21 abstract only.
Evans et al, Aquaculture, 2004, 233:15-21.
Kawamura et al, International J. Systematic & Evolutionary Microbiology, 2005, 55:961-965.
Pasnik et al, J. Fish Diseases, 2005, 28:205-212.
Pasnik et al, Fish & Shellfish Immunology, 2006, pp. 1-7 (Article In Press).
Pasnik et al, Diseases of Aquatic Organisms, 2005, 66:129-134.
Abid et al, Lymphokine and Cytokine Research, 1991, 10/1:43-50.
Teska et al, Biomedical Letters, 1994, 50:195-201.
Berrodge et al, Vet. Microbiology, 2001, 78:165-173.
Kawamura et al, Antimicrobial Agents and Chemotherapy, Nov. 2003, 47/11:3605-3609.
Passnik et al, Fish & Shellfish Immunology, 2006, 21:365-371.
Hughes et al, FEMS Microbiology Letters, 2003, 222:263-271.
Evans et al, J. Fish Diseases, 2002, 25:505-513.
Tikkanen et al, J. Immunological Methods, 1995, 187:233-244.
Spellerberg, Microbes and Infection, 2000, 2:1733-1742.
Jarva et al, Molecular Immunology, 2003, 40:95-107.
Pasnik et al, J. Fish Disease, Apr. 2005, 28/4:205/212 (Abstract Only).
Avi Eldar et al., “Experimental Streptococcal Meningo-Encephalitis in Cultured Fish,”Veterinary Microbiology 43(1995) pp. 33-40.
P.H. Klesius et al., “Vaccination Stress in Nile Tilapia,Oreochromis niloticus,” Presented at the European Associated Fish Patrol inSep. 22-23, 2003.
A. Eldar et al., “Development and Efficacy of a Vaccine AgainstStreptococcus iniaeInfection in Farmed Rainbow Trout,”Veterinary Immunology and Immunopathology 56(1997) pp. 175-183.
J.J. Evans et al., “Characterization of β-haemolytic Group BStreptococcus agalactiaein cultured seabream,Sparus auratusL., and Wild Mullet,Liza klunzingeri(Day), in Kuwait,”Journal of Fish Diseases 2002, 25, 505-513.
P. Vandamme et al., “Streptococcus difficileis a Nonhemolytic Group B, Type lbStreptococcus,” International Journal of Systematic Bacteriology, Jan. 1997, pp. 81-85, vol. 47, No. 1.
Avi Eldar et al., “Vaccination with Whole-Cell Vaccine and Bacterial Protein Extract Protects Tilapia againstStreptococcus difficilemeningoencephalitis,”Vaccinevol. 13, No. 9, pp. 867-870, 1995.
M. Akhlaghi et al., “Comparison of Passive and Active Immunization of Fish against Streptococcosis (Enterococcosis),”Journal of Fish diseases 1996, 19, pp. 154-258.
Donald F. Amend, “Potency Testing of Fish Vaccines,” International Symposium in Fish Biologics: Serodiagnostics and Vaccines, Leetown, W. VA, 1981,Develop. Biol. Standard, 49, pp. 447-454 (S. Karger, Basel 1981).
A.M. Baya et al., “Association ofStreptococcussp. with Fish Mortalities in the Chesapeake Bay and its Tributaries,”Journal of Fish Diseases 1990, 13, pp. 251-253.
H. Bercovier et al., “Immunization with Bacterial Antigens: Infections with Streptococci and Related Organisms,” Gudding R. Lillehaug A. Midtlyng PJ, Brown F (eds): Fish Vaccinology..Dev Biol Stand. Basel, Karger,1997, vol. 90, pp. 153-160.
David W. Cook et al., “Pathogenicity Studies with aStreptococcussp. Isolated from Fishes in an Alabama-Florida Fish Kill,”Trans. Amer. Fish. Soc., 1975, No. 2 pp. 286-288.
John A. Elliott et al., “Whole-Cell Protein Patterns of Nonhemolytic Group B, Type lb, Streptococci Isolated from Humans, Mice, Cattle, Frogs, and Fish,”Journal of Clinical Microbiology, Mar. 1990. pp. 628-630
Patricia M. Glibert et al., “A Fish Kill of Massive Proportion in Kuwait Bay, Arabian Gulf, 2001: the Roles of Bacterial Disease, Harmful Algae, and Eutrophiction,”Harmful Algae 1(2002) 215-231.
Phillip H. Klesius et al., “Efficacy of Single and CombinedStreptococcus iniaeIsolate Vaccine Administered by Intraperitoneal and Intramuscular Routes in Tilapia (Oreochromis niloticus),”Aquaculture 188(2000) 237-246.
Phillip H. Klesius et al., “Efficacy of a KilledStreptococcus iniaeVaccine in Talapia (Oreochromis niloticus),”Bull. Eur. Ass. Fish Pathol., 19(1),39,1999.
Riichi Kusuda et al., “A Comparative Study of Fish PathogenicStreptococcusIsolated from Saltwater and freshwater Fishes,”Bulletin of the Japanese Society of Scientific Fisheries 44(10) 1073-1078 (1978).
Teruyuki Nakanishi et al., “Development of a New Vaccine Delivery Method for Fish: Percutaneous Administration by Immersion with Application of a Multiple Puncture Instrument,”Vaccine 20(2002) 3764-3769.
J.A. Plumb et al., “Streptococcussp. from Marine Fishes Along the Alabama and Northwest Florida Coast of the Gulf of Mexico,”Transactions of American Fisheries Society 2, 358-361.
Victoria Rasheed et al., “histopathology of Bullminnows,Fundulus grandisBaird & Girard, Infected with a Non-haemolytic Group BStreptococcussp.,”Journal of Fish Diseases 1985,8, 65-74.
Victoria Rasheed et al., “Pathogenicity of a Non-haemolytic Group BStreptococcussp. in Gulf Killifish (Fundulus grandisBaird and Girard),”Aquaculture, 37 (1984) 97-105.
Jordan A. Robinson et al., “Streptococcal Fish Pathogen,”Journal of Bacteriology, Aug. 1966 vo. 92, No. 2 p. 512.
Romalde, J.L. et al., “Prevention of Streptococcosis in Turbot by Intraperitoneal Vaccination: a review,”J. Appl. Ichthyol. 15, 153-158.
Jesus L. Romalde et al., “Long-Lasting Protection Against Turbot Streptococcosis Obtained with a Toxoid-Enriched Bacterin,”Bull Eur. Ass. Fish pathol., 16(5), 169, 1996.
A.E. Toranzo et al., “Efficacy of Intraperitoneal and Immersion Vaccination againstEnterococcussp. Infection in Turbot,”Aquaculture 134:17-27.
P. Vandamme et al., “Streptococcus difficileis a Nonhemolytic Group B, Type lbStreptococcus,” International Journal of Systematic Bacteriology Jan. 1997pp. 81-85 vol. 47 No. 1.
Hazel W. Wilkinson et al., “Nonhemolytic Group B Streptococci of Human, Bovine, and Ichthyic Origin,”Infection and Immunity Mar. 1973vol. 7, 496-498.
Evans Joyce J.
Klesius Phillip H.
Shoemaker Craig A.
Deck Randall E.
Fado John
Minnifield Nito
Shaw Lesley
The United States of America as represented by the Secretary of
LandOfFree
Streptococcus agalactiae vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Streptococcus agalactiae vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Streptococcus agalactiae vaccine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3748774